{"id":31,"date":"2026-02-04T00:00:05","date_gmt":"2026-02-04T00:00:05","guid":{"rendered":"http:\/\/totesa.website\/student\/?page_id=31"},"modified":"2026-05-09T20:39:29","modified_gmt":"2026-05-09T20:39:29","slug":"about-me","status":"publish","type":"page","link":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/","title":{"rendered":"Andy Mostajo"},"content":{"rendered":"\n<p>Draw me a cell!<\/p>\n\n\n\n<div data-wp-interactive=\"\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!selectors.core.file.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/02\/osteoclast-drawing-1.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of osteoclast-drawing-1.\"><\/object><a id=\"wp-block-file--media-df782112-2dd1-427b-becf-69a78fc04fa7\" href=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/02\/osteoclast-drawing-1.pdf\">osteoclast-drawing-1<\/a><a href=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/02\/osteoclast-drawing-1.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-df782112-2dd1-427b-becf-69a78fc04fa7\">Download<\/a><\/div>\n\n\n\n<p>Draw me a biololecule! <\/p>\n\n\n\n<p>This is the Biomolecule Alpha helix with 3 amino acids<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"720\" src=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2.jpg\" alt=\"\" class=\"wp-image-240\" srcset=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2.jpg 960w, https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2-300x225.jpg 300w, https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2-768x576.jpg 768w, https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Biomolecule-alpha-helix-2-400x300.jpg 400w\" sizes=\"(max-width: 960px) 100vw, 960px\" \/><\/a><\/figure>\n\n\n\n<p>Make a meme! <\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Cell-Bio-meme-1-1.jpg\"><img loading=\"lazy\" decoding=\"async\" width=\"500\" height=\"649\" src=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Cell-Bio-meme-1-1.jpg\" alt=\"\" class=\"wp-image-242\" srcset=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Cell-Bio-meme-1-1.jpg 500w, https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-content\/uploads\/sites\/40634\/2026\/05\/Cell-Bio-meme-1-1-231x300.jpg 231w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/a><\/figure>\n\n\n\n<p>Meme caption<br>I created this meme because I never realized how much historical value the ribosome<br>has in cell biology. I feel as though I would have thought the ribosome was as cool as<br>the mitochondria in high school.<\/p>\n\n\n\n<p>Scientific literacy paper<\/p>\n\n\n\n<p>Strengths and Weaknesses of Animal Testing<\/p>\n\n\n\n<p>Animal testing is a scientific practice that has been used since the times of the Greeks and Romans.\u00a0 It has proven valuable for drug and medical procedure testing. However, animal testing efficacy has undergone some scrutiny in recent years and is now being phased out. To understand the reasoning behind this, a comprehensive list of the benefits and deficits of animal testing is necessary.\u00a0<\/p>\n\n\n\n<p>Animal testing allows the use of invasive and potentially dangerous testing of medical practices and products on non-human organisms.&nbsp; A shining example of this is the 1983 Federal Food, Drug, cosmetic act. This act required the use of animal testing on all drugs before they could be mass-produced and distributed to prevent any harm to the public. In addition to that, animals have also been used in research in transplant immunology, paving the way for organ transplants and even temporary transplants through the use of pig organs. It is indisputable that animal testing has served as a sturdy foundation for medical transplantation practices. Animal testing was also instrumental in one of the first comprehensive journals on the vascular system, created by William Harvey. Through this, he was able to dispel any dated beliefs, including the 4 humerus. It was through careful testing of unfortunate live animals that he was able to observe how the vascular system functions. Scientists also conducted animal testing to understand bodily movement and stimulation. Charles Sherrington and Eccles studied how the central nervous system elicits movement and laid the foundations for a doctor&#8217;s ability to perform surgery on the brain without damaging motor function.&nbsp;<\/p>\n\n\n\n<p>Animal testing has proven instrumental to medical science in the past and continues to do so, but its modern-day impacts fall short of its past achievements. It is currently estimated that 90 percent of drugs that show effectiveness in animal testing fail in human trials. Although the animals used, such as rats and primates, share a genome similar to that of humans, the way DNA is expressed in other animals differs. Additionally, a lab environment creates unavoidable variables in lab testing. Handling animals in any sort of way increases stress and cortisol levels, creating difficult variables to circumvent. There have also been many cases in which animal testing has misled scientists and researchers to believe that an experimental drug was safe for human testing. An example of this is the drug TGN 1412 causing organ failure in humans soon after administration but causes no such effect in animal trials. There is also, of course, the ethics of using live animals for testing. This has been a long-standing debate since the inception of animal testing. At first, it was stated that animals do not experience pain or other emotional responses as humans do, but after much examination and testing, it is widely accepted that animals are capable of feeling stress and pain. Testing animals are bred in captivity, away from their natural environments, and often isolated from other animals. Many animals are also capable of complex problem-solving and self-awareness. Finally, there are more effective alternatives to animal testing. Organoid toxicity testing and AI models have shown great promise for an effective way to test drugs. In fact, this seems to be the main driver to phase out animal testing. Organoids are a 3D cellular model made in vitro. They are an accurate representation of the tissue of a desired human organ, which makes them great for testing purposes. This, in combination with predictive toxicology AI models, creates a paradigm shift in drug testing, causing animal testing to be a lesser option now, considering its discussed deficits.\u00a0<\/p>\n\n\n\n<p>Animal testing has proven to be instrumental in creating the foundation of the medical understanding of anatomy, as well as serving as a launch pad for drug testing. It has played a significant role in creating various vaccines and surgical practices. However, its defects, including misleading expectations for human trials, a low rate of successful animal trials to successful human trials, ethical concerns, and new technologies, have led to a replacement of animal testing. The practice has seemed to have served its purpose, and it is time to make way for new technologies.\u00a0<\/p>\n\n\n\n<p>AKHTAR, A. (2015). The Flaws and Human Harms of Animal Experimentation. <em>Cambridge Quarterly of Healthcare Ethics<\/em>, <em>24<\/em>(4), 407. <a href=\"https:\/\/doi.org\/10.1017\/S0963180115000079\">https:\/\/doi.org\/10.1017\/S0963180115000079<\/a> <\/p>\n\n\n\n<p>Scientific Literacy 2: New Approach Methodologies&nbsp;<\/p>\n\n\n\n<p>New approach methodologies (NAM\u2019s) are innovative scientific technologies that aim to improve drug and chemical testing. The most modern and promising technologies are organ chips, organoids, and generative AI systems. These methodologies have been growing rapidly since 2006 and, conversely, have led to a decline in animal experimentation. Organ chips and 3D organoids, for example, can create more accurate molecular environments than genetically similar animals due to their ability to utilize human-derived induced pluripotent stem cells (iPSCs). The AI systems can take in necessary data to create predictive models of chemical and drug outcomes without the ethical concerns of animal testing. However, more complex scenarios require animal testing due to the NAM\u2019s inability to analyze drug and chemical effects on complex systems like the endocrine system or whole organs.\u00a0<\/p>\n\n\n\n<p>Microfluidic organs-on-chips and 3D organoids are essentially lab-grown organ tissues. They are created through the use of human-derived induced pluripotent stem cells or iPSCs. A person of interest who has the desired disease to be tested will provide a tissue sample, often from the skin or blood, and turn the cells into a stem cell by adding certain transcription factors known as Yamanaka factors (Liu et al., 2008). iPSCs are essential for the creation of organ chips and 3D organoids because of their ability to self-replicate into any desired cell (NIH, 2016). By modifying the cells, we can create organ tissue samples in vitro and test them. This is intrinsically better than animal testing because the variables are more controlled, and the gene expression of the cells is identical to humans, because it&#8217;s a human sample.&nbsp; Different organisms express their genome differently, so although the animals that are tested on have a fairly similar genome to humans, the difference in expression can complicate testing. This is why iPSCs are so important for 3D organoids and organ chips, and they can only become more accurate through the use of AI.&nbsp;<\/p>\n\n\n\n<p>AI systems have proved to be an instrumental tool for NAMs through the use of their multimodal learning, generative modeling, and causal inference. Toxicology has a large amount of data to work through, and that is an area where AI systems can excel. It can optimize workflows by organizing them and flagging any incongruent patterns (Luechtefeld &amp; Hartung, 2025).&nbsp; It can also run many simulations to predict the effectiveness of certain drugs and chemicals. It is also important to note that it does not do this automatically and runs alongside toxicologists as a form of \u201ce-validation\u201d. It is effective at creating risk assessments and synthesizing evidence and is more accurate than animal testing (Luechtefeld &amp; Hartung, 2025). An example of this is the use of SSL techniques to identify outliers in chemical graphs and ensure accuracy. Additionally, synthetic data generation can be used to create artificial data to fill in the gaps of analysis. In toxicology, there is often a lack of data necessary to experiment, so AI models can be used to fill that gap with synthetic data that is similar to the base data of the experiment.&nbsp;<\/p>\n\n\n\n<p>AI technology, organ chips, and 3D organelles are evidently valuable to drug testing and allow a more humane and accurate form of experimentation, but they can not completely replace animal testing. For example, AI systems suffer from the black box nature of their data calculations. The patterns and data it uses to come to its conclusions can not be viewed by scientists because of its complex neural network. AI systems can also be heavily affected by bias if the data sets they are trained on are not diverse enough (Luechtefeld &amp; Hartung, 2025). This causes hesitancy of trust among many toxicological scientists, as these defects can heavily affect the results of experiments if the AI&#8217;s results are not validated. Additionally, 3D organoids and microfluidic organs-on-chips are limited to simpler structures that lack vasculature. Animal testing will continue to be used for testing on chemicals and drugs that have a wider range of effects. Organoids and organ chips also need a high degree of quality control in order to produce consistent and replicable results. This can often lead to very long production of these testing mediums (Park et al., 2024).&nbsp;<\/p>\n\n\n\n<p>Despite the flaws that prevent it from replacing animal testing, NAMs are a paradigm shift in toxicological technology. Creating artificial organ tissue from human samples creates the most accurate test results for chemicals and drugs, and AI systems streamline the analysis of results and fill in the gaps through simulations. Though they may not be able to simulate the results in more complex experiments and can take time to prepare, NAMs have plenty of room to improve as the most efficient and ethical form of toxicological testing.&nbsp;<\/p>\n\n\n\n<p>Refrances<\/p>\n\n\n\n<p>Kwon, D. (2026). The age of animal experiments is waning. Where will science go next? <em>Nature<\/em>, <em>650<\/em>(8103), 812\u2013814. https:\/\/doi.org\/10.1038\/d41586-026-00563-3<\/p>\n\n\n\n<p>Liu, X., Huang, J., Chen, T., Wang, Y., Xin, S., Li, J., Pei, G., &amp; Kang, J. (2008). Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. <em>Cell Research<\/em>, <em>18<\/em>(12), 1177\u20131189. https:\/\/doi.org\/10.1038\/cr.2008.309<\/p>\n\n\n\n<p>Luechtefeld, T., &amp; Hartung, T. (2025). Navigating the AI Frontier in Toxicology: Trends, Trust, and Transformation. <em>Current Environmental Health Reports<\/em>, <em>12<\/em>(1). https:\/\/doi.org\/10.1007\/s40572-025-00514-6<\/p>\n\n\n\n<p>NIH. (2016). <em>Stem Cell Basics<\/em>. Stemcells.nih.gov; National Institutes of Health. https:\/\/stemcells.nih.gov\/info\/basics\/stc-basics<\/p>\n\n\n\n<p>Park, G., Yeri Alice Rim, Sohn, Y., Nam, Y., &amp; Ji Hyeon Ju. (2024). Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations. <em>Stem Cell Reviews and Reports<\/em>, <em>20<\/em>(6). https:\/\/doi.org\/10.1007\/s12015-024-10723-5<\/p>\n\n\n\n<p>End of term reflection <\/p>\n\n\n\n<p>Cell biology has allowed me to better understand how genetic diseases occur. With this knowledge, I can assist my future patients in the future more effectively. For example, Osteoarthritis is a congenital disease that weakens the bones in the body. This occurs due to a mutation in the LRP5 gene, which then creates overactivity in osteoclast cells. With this deeper knowledge of the cell and genome, I can further assist patients with the disease. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Draw me a cell! Draw me a biololecule! This is the Biomolecule Alpha helix with 3 amino acids Make a meme! Meme captionI created this meme because I never realized how much historical value the ribosomehas in cell biology. I feel as though I would have thought the ribosome was as cool asthe mitochondria in&#8230; <\/p>\n<div class=\"link-more\"><a href=\"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/\">Read More<\/a><\/div>\n","protected":false},"author":30179,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/pages\/31"}],"collection":[{"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/users\/30179"}],"replies":[{"embeddable":true,"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/comments?post=31"}],"version-history":[{"count":5,"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/pages\/31\/revisions"}],"predecessor-version":[{"id":244,"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/pages\/31\/revisions\/244"}],"wp:attachment":[{"href":"https:\/\/sites.wp.odu.edu\/andymostajo-cellbio\/wp-json\/wp\/v2\/media?parent=31"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}